[Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].

MLA

Postma, M. J., et al. “[Screening for Asymptomatic Chlamydia Trachomatis Infection in Pregnancy; Cost-Effectiveness Favorable at a Minimum Prevalence Rate of 3% or More].” Nederlands Tijdschrift Voor Geneeskunde, vol. 144, no. 49, Dec. 2000, pp. 2350–54. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=11129971&authtype=sso&custid=ns315887.

APA

Postma, M. J., Bakker, A., Welte, R., van Bergen, J. E., van den Hoek, J. A., de Jong-van den Berg, L. T., & Jager, J. C. (2000). [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more]. Nederlands Tijdschrift Voor Geneeskunde, 144(49), 2350–2354.

Chicago

Postma, M J, A Bakker, R Welte, J E van Bergen, J A van den Hoek, L T de Jong-van den Berg, and J C Jager. 2000. “[Screening for Asymptomatic Chlamydia Trachomatis Infection in Pregnancy; Cost-Effectiveness Favorable at a Minimum Prevalence Rate of 3% or More].” Nederlands Tijdschrift Voor Geneeskunde 144 (49): 2350–54. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=11129971&authtype=sso&custid=ns315887.